Resources/
Phil Blog

Phil Blog

8 Patient Access Trends Pharma Leaders Should Consider in 2025

With a new year brings new brand goals. Retail and specialty-lite brand teams continue to face an evolving patient access landscape that's significantly impacting their commercialization strategies. From the expansion of direct-to-consumer (DTC) models to the growing importance of real-world evidence, these emerging trends are reshaping how patients interact with healthcare systems and access prescribed therapies

Meet Maria Klagos, VP People Operations at PHIL

In our latest employee spotlight, we sit down with Maria Klagos, our new Head of People, who brings a wealth of experience in scaling HR functions at high-growth startups. We explore her unique background, her vision for PHIL’s culture, and the personal experiences that have shaped her professional journey. Please tell us a little bit about yourself and your new role at PHIL I joined PHIL as the VP of People Operations this past May

Transforming the Patient Experience with a Strong Direct-to-Consumer Program

The pharmaceutical industry has undergone a digital transformation – as of 2024, over 75% of patients have accessed care virtually. Leading brands across the industry are embracing direct-to-consumer (DTC) programs to meet modern patient needs. If you’re not considering how this access strategy could benefit your stakeholders, you may be missing out on the opportunity to better serve your patients and providers while driving brand performance

Meet Chris Sweitzer, VP of Business Development at PHIL

In this employee spotlight interview, we are excited to feature Chris Sweitzer, our new Vice President of Business Development at PHIL. With two decades of experience in the healthcare industry and a passion for enhancing patient access, Chris brings a wealth of knowledge and a unique perspective to our team. Please tell us a little bit about yourself and your role at PHIL

Integrating Telemedicine Into Your Pharmaceutical Brand’s DTC Strategy

The popularity of direct-to-consumer (DTC) channels across industries has fueled patients’ expectations for convenience, cost savings, and improved access to healthcare services. While the COVID-19 pandemic cemented the idea that telemedicine can be a critical part of a pharmaceutical brand’s go-to-market strategy, it’s essential to recognize that it is just one piece of the puzzle. To truly transform the patient experience and improve brand outcomes, pharmaceutical brand teams need to integrate a telemedicine channel within a broader DTC strategy